Endo-Vascular Investigation Determining the Safety of a New Tacrolimus Eluting Stent Graft - EVIDENT


Evaluation of a tacrolimus-eluting stent graft designed for diseased saphenous vein bypass grafts.

Study Design

Study Design:

Patients Enrolled: 15

Primary Endpoints:

Death, MI, TVR

Drug/Procedures Used:

15 patients received the stent graft coated with 322 mcg tacrolimus.

Principal Findings:

No events have been observed.


Results are pending.

Clinical Topics: Invasive Cardiovascular Angiography and Intervention, Atherosclerotic Disease (CAD/PAD), Interventions and Coronary Artery Disease

Keywords: Coronary Artery Disease, Drug-Eluting Stents, Saphenous Vein, Tacrolimus

< Back to Listings